Bank Hapoalim BM’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.38M Sell
30,400
-60
-0.2% -$4.69K 0.32% 53
2025
Q1
$2.21M Buy
30,460
+2,120
+7% +$154K 0.32% 54
2024
Q4
$2.1M Sell
28,340
-1,125
-4% -$83.3K 0.34% 54
2024
Q3
$1.94M Hold
29,465
0.29% 63
2024
Q2
$2.72M Sell
29,465
-2,500
-8% -$231K 0.38% 57
2024
Q1
$3.06M Buy
31,965
+19,565
+158% +$1.87M 0.4% 55
2023
Q4
$946K Buy
12,400
+5,500
+80% +$420K 0.13% 93
2023
Q3
$478K Buy
6,900
+700
+11% +$48.5K 0.08% 105
2023
Q2
$585K Hold
6,200
0.08% 120
2023
Q1
$513K Sell
6,200
-50
-0.8% -$4.14K 0.07% 134
2022
Q4
$466K Sell
6,250
-500
-7% -$37.3K 0.06% 140
2022
Q3
$558K Buy
6,750
+299
+5% +$24.7K 0.07% 134
2022
Q2
$613K Buy
6,451
+1,201
+23% +$114K 0.08% 138
2022
Q1
$618K Sell
5,250
-2,015
-28% -$237K 0.06% 150
2021
Q4
$941K Sell
7,265
-260
-3% -$33.7K 0.09% 136
2021
Q3
$852K Hold
7,525
0.09% 137
2021
Q2
$779K Buy
7,525
+400
+6% +$41.4K 0.09% 144
2021
Q1
$596K Hold
7,125
0.08% 148
2020
Q4
$650K Sell
7,125
-1,450
-17% -$132K 0.09% 126
2020
Q3
$684 Sell
8,575
-743
-8% -$59 0.03% 100
2020
Q2
$644K Sell
9,318
-51
-0.5% -$3.53K 0.15% 104
2020
Q1
$589K Buy
9,369
+225
+2% +$14.1K 0.19% 90
2019
Q4
$711K Buy
9,144
+1,113
+14% +$86.5K 0.16% 88
2019
Q3
$582K Hold
8,031
0.14% 95
2019
Q2
$495K Buy
8,031
+681
+9% +$42K 0.12% 109
2019
Q1
$469K Sell
7,350
-3,030
-29% -$193K 0.11% 106
2018
Q4
$530K Sell
10,380
-1,359
-12% -$69.4K 0.17% 94
2018
Q3
$681K Buy
11,739
+549
+5% +$31.8K 0.17% 97
2018
Q2
$543K Buy
11,190
+1,050
+10% +$51K 0.15% 122
2018
Q1
$472K Sell
10,140
-13,725
-58% -$639K 0.12% 118
2017
Q4
$897 Buy
23,865
+2,850
+14% +$107 0.2% 86
2017
Q3
$766K Buy
+21,015
New +$766K 0.17% 103